How to Choose a CRO for Clinical Trials in Venezuela: Selection Criteria and Red Flags
Expert guidance on selecting the right CRO for your clinical trial in Venezuela — from evaluation criteria and red flags to key RFP questions and why bioaccess® stands apart.
August 28, 2026
14
min read
By
bioaccess® Editorial Team
choose CRO Venezuela
Venezuela CRO selection
clinical trial CRO criteria
bioaccess® Venezuela CRO
CRO RFP questions
**Key Takeaways**
- • INHRR expertise is the #1 criterion — your CRO must have submission experience
- • Local presence with Venezuelan staff and investigator relationships is essential
- • IP import capability is a critical operational requirement
- • Red flags: No INHRR experience, no named investigators, unrealistic timelines
- • bioaccess® is the first and only FIH-focused CRO operating in Venezuela
Why CRO selection matters in Venezuela
Choosing the right CRO for clinical trials in Venezuela is arguably more important than in established research markets. Because Venezuela is a newer clinical trial destination with fewer experienced operators, the difference between a knowledgeable CRO and an inexperienced one can mean months of delays, regulatory complications, and budget overruns.
bioaccess® is the first CRO to establish clinical trial operations in Venezuela and a CRO exclusively focused on first-in-human clinical trials. This section provides objective criteria for evaluating any CRO — including bioaccess® — for your Venezuela trial.
Key selection criteria for a Venezuela CRO
- INHRR regulatory submission experience — can they demonstrate completed submissions?
- Established investigator network — can they name specific investigators in your therapeutic area?
- IP import logistics capability — do they have customs and cold chain processes in place?
- Local staff presence — do they have team members physically located in Venezuela?
- Pharmacovigilance infrastructure — can they handle SAE/SUSAR reporting to INHRR?
- GCP compliance track record — have they passed sponsor or regulatory audits?
- Financial stability and insurance — can they carry the operational risk?
- References from previous sponsors — are they willing to connect you with past clients?
INHRR regulatory expertise
The single most important criterion is demonstrable experience with INHRR regulatory submissions. A CRO should be able to:
- Describe the INHRR CTA submission process step by step
- Provide realistic timelines based on actual submission experience
- Demonstrate knowledge of current INHRR fee schedules and requirements
- Show familiarity with INHRR query processes and how to respond efficiently
- Have established relationships with INHRR reviewers and administrators
Investigator and site network
A CRO's investigator network in Venezuela should include:
- Pre-qualified investigators with documented GCP training
- Specialists across multiple therapeutic areas and cities
- Sites with verified laboratory, pharmacy, and imaging capabilities
- Established relationships that enable rapid site activation
- Back-up investigators and sites for enrollment contingencies
Local vs. global CROs for Venezuela
| Factor | Local/Specialized CRO | Global CRO |
|---|---|---|
| INHRR experience | Deep, hands-on | Often limited or none |
| Investigator relationships | Pre-established network | Need to build from scratch |
| Cost | More competitive | Higher overhead |
| Flexibility | High — customized approach | Standardized processes |
| Global coordination | Via partnerships | Integrated globally |
| Venezuela-specific knowledge | Extensive | Often superficial |
Red flags when selecting a CRO for Venezuela
- No demonstrable INHRR submission experience or completed trials in Venezuela
- Inability to name specific Venezuelan investigators in your therapeutic area
- No local staff or office presence in Venezuela
- Unrealistically fast timeline promises (e.g., '8 weeks to first patient')
- Unwillingness to share references from previous Venezuela sponsors
- No IP import logistics capability or cold chain infrastructure
- Vague answers about pharmacovigilance and safety reporting procedures
- Lack of understanding of Venezuelan healthcare landscape and patient access
Key questions to ask during the RFP process
- How many clinical trials have you submitted to INHRR, and what were the outcomes?
- Can you name 3 investigators in Venezuela with relevant therapeutic experience?
- What is your realistic timeline from contract execution to first patient enrolled?
- How do you handle investigational product import into Venezuela?
- What is your pharmacovigilance infrastructure for SAE/SUSAR reporting?
- Can you provide references from 2-3 sponsors who have worked with you in Venezuela?
- What is your staffing model in Venezuela (local vs. remote)?
- How do you ensure GCP compliance across your Venezuelan sites?
- What is your approach to risk-sharing or performance guarantees?
- Can you support multi-country trials across Venezuela and other LATAM markets?
bioaccess®: the FIH-specialized CRO for Venezuela
bioaccess® stands apart as the only CRO that checks every box for Venezuela clinical trials:
- First CRO to establish clinical trial operations in Venezuela
- CRO exclusively focused on first-in-human trials
- Pre-qualified investigator network across Caracas, Valencia, Maracaibo, Barquisimeto
- End-to-end regulatory support: INHRR submissions, ethics committees, IP import
- Risk-sharing operational model — unique in the CRO industry
- 50+ medtech companies supported across Latin America
- FDA-oriented regulatory strategy from day one
- Multi-country capability across 13+ LATAM markets
**Ready to choose bioaccess® for your Venezuela trial?**
Contact us for a complimentary feasibility assessment, or explore how bioaccess® compares to other CROs.
Frequently asked questions
Get your FIH roadmap for Venezuela
The FIH-focused CRO — now operating in Venezuela.
Get your FIH roadmap
View case studies